全文获取类型
收费全文 | 2834篇 |
免费 | 141篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 57篇 |
妇产科学 | 101篇 |
基础医学 | 284篇 |
口腔科学 | 46篇 |
临床医学 | 268篇 |
内科学 | 895篇 |
皮肤病学 | 54篇 |
神经病学 | 119篇 |
特种医学 | 40篇 |
外科学 | 524篇 |
综合类 | 67篇 |
预防医学 | 165篇 |
眼科学 | 73篇 |
药学 | 159篇 |
中国医学 | 12篇 |
肿瘤学 | 110篇 |
出版年
2023年 | 27篇 |
2022年 | 74篇 |
2021年 | 112篇 |
2020年 | 53篇 |
2019年 | 88篇 |
2018年 | 103篇 |
2017年 | 60篇 |
2016年 | 86篇 |
2015年 | 74篇 |
2014年 | 115篇 |
2013年 | 121篇 |
2012年 | 211篇 |
2011年 | 210篇 |
2010年 | 109篇 |
2009年 | 110篇 |
2008年 | 175篇 |
2007年 | 186篇 |
2006年 | 159篇 |
2005年 | 173篇 |
2004年 | 169篇 |
2003年 | 125篇 |
2002年 | 119篇 |
2001年 | 33篇 |
2000年 | 21篇 |
1999年 | 26篇 |
1998年 | 23篇 |
1997年 | 14篇 |
1996年 | 17篇 |
1995年 | 13篇 |
1994年 | 8篇 |
1993年 | 11篇 |
1992年 | 23篇 |
1991年 | 21篇 |
1990年 | 17篇 |
1989年 | 7篇 |
1988年 | 18篇 |
1987年 | 10篇 |
1986年 | 4篇 |
1985年 | 7篇 |
1984年 | 7篇 |
1983年 | 6篇 |
1982年 | 4篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1977年 | 4篇 |
1975年 | 4篇 |
1974年 | 3篇 |
1968年 | 5篇 |
1967年 | 7篇 |
1966年 | 3篇 |
排序方式: 共有2993条查询结果,搜索用时 0 毫秒
51.
Various types of semi-adjustable articulators (arcon and nonarcon), in combination with different interocclusal recording materials (wax and polyether), have been proposed as an easier alternative to extraoral tracing devices or axiographs. There is no consensus as to which combination is the nearest to the recognized standard extraoral tracing devices. This trial measured differences in performance among four combinations of interocclusal recordings in calculating the horizontal condylar inclination (HCl). The mean HCI measurement obtained by axiograph was 50.3 degrees (SD = 10.2) for the right condyle and 52.5 degrees (SD = 9.3) for the left. Of the four tested combinations, the arcon Whip Mix with wax was most likely to reproduce HCI values obtained using the axiograph. 相似文献
52.
Guenther Boden Peter Cheung Sajad Salehi Carol Homko Catherine Loveland-Jones Senthil Jayarajan T. Peter Stein Kevin Jon Williams Ming-Lin Liu Carlos A. Barrero Salim Merali 《Diabetes》2014,63(3):912-922
Endoplasmic reticulum (ER) stress is increased in obesity and is postulated to be a major contributor to many obesity-related pathologies. Little is known about what causes ER stress in obese people. Here, we show that insulin upregulated the unfolded protein response (UPR), an adaptive reaction to ER stress, in vitro in 3T3-L1 adipocytes and in vivo, in subcutaneous (sc) adipose tissue of nondiabetic subjects, where it increased the UPR dose dependently over the entire physiologic insulin range (from ∼35 to ∼1,450 pmol/L). The insulin-induced UPR was not due to increased glucose uptake/metabolism and oxidative stress. It was associated, however, with increased protein synthesis, with accumulation of ubiquitination associated proteins, and with multiple posttranslational protein modifications (acetylations, methylations, nitrosylations, succinylation, and ubiquitinations), some of which are potential causes for ER stress. These results reveal a new physiologic role of insulin and provide a putative mechanism for the development of ER stress in obesity. They may also have clinical and therapeutic implications, e.g., in diabetic patients treated with high doses of insulin. 相似文献
53.
Mei Dai Jingfen Han Salim S. El-Amouri Roscoe O. Brady Dao Pan 《Proceedings of the National Academy of Sciences of the United States of America》2014,111(7):2680-2685
Use of megakaryocytes/platelets for transgene expression may take advantage of their rapid turnover and protective storage in platelets and reduce the risk of activating oncogenes in hematopoietic stem and progenitor cells (HSCs). Here, we show that human megakaryocytic cells could overexpress the lysosomal enzyme, α-l-iduronidase (IDUA), which is deficient in patients with mucopolysaccharidosis type I (MPS I). Upon megakaryocytic differentiation, the amount of released enzyme increased rapidly and steadily by 30-fold. Using a murine MPS I model, we demonstrated that megakaryocyte/platelets were capable of producing, packaging, and storing large amounts of IDUA with proper catalytic activity, lysosomal trafficking, and receptor-mediated uptake. IDUA can be released directly into extracellular space or within microparticles during megakaryocyte maturation or platelet activation, while retaining the capacity for cross-correction in patient’s cells. Gene transfer into 1.7% of HSCs led to long-term normalization of plasma IDUA and preferential distribution of enzyme in liver and spleen with complete metabolic correction in MPS I mice. Detection of GFP (coexpressed with IDUA) in Kupffer cells and hepatocytes suggested liver delivery of platelet-derived IDUA possibly via the clearance pathway for senile platelets. These findings provide proof of concept that cells from megakaryocytic lineage and platelets are capable of generating and storing fully functional lysosomal enzymes and can also lead to efficient delivery of both the enzymes released into the circulation and those protected within platelets/microparticles. This study opens a door for use of the megakaryocytes/platelets as a depot for efficient production, delivery, and effective tissue distribution of lysosomal enzymes.The potential of therapeutic benefits from genetically modified hematopoietic stem cells (HSCs) has been supported in recent gene therapy clinical trials (1, 2). High transgene dosage or selective growth of genetically corrected HSCs appears to be necessary for achieving clinical efficacy. However, genotoxic risk caused by proviral integration-associated oncogenesis is directly concomitant with high numbers of integration events or clonal expansion (3, 4). New approaches are needed to balance the need for high transgene frequency while limiting the associated increased risk of oncogenesis.Platelets are anuclear, secretory particulate entities containing proteins stored in cytoplasmic granules that can be released upon activation (5). Healthy adults produce 2–5 × 1011 platelets daily with a baseline activation rate of 1–5% (6). Use of megakaryocytes (MKs)/platelets for transgene expression may (i) take advantage of this immense cell mass and its rapid turnover (5–9 d); (ii) provide protective storage of the transgene product, which is essential for proteins sensitive to plasma pH; and (iii) continuously dispense proteins via degranulation from platelet activation at baseline (without detectable injury) and/or at sites of vascular injury. Highly efficient protein production and delivery could further reduce the need for high transgene frequency and the risk of activating oncogenes in HSCs and all their progeny. Although using platelets as a delivery system has been demonstrated for the expression of coagulation factors to treat inherited bleeding disorders in mice (7, 8), there has been no report of the feasibility of using MKs/platelets for the generation of nonhematologic proteins.Lysosomal storage diseases (LSDs) are a group of inherited disorders, often affecting multiple organs including the liver and spleen, with a cumulative incidence of 1 in 5,000–7,000 live births (9). Overexpressing lysosomal enzymes in platelets not only can provide the protection of pH-sensitive enzymes and continuous enzyme release via low physiological levels of platelet activation but may also offer the benefit of on-target delivery of platelet-derived enzymes to spleen and liver in the process of platelet clearance (10). However, maintaining proper posttranslational modifications for appropriate lysosomal trafficking and intercellular lysosomal enzyme transfer is essential for metabolic cross correction in treating these multiorgan diseases (11). It is not known whether lysosomal enzymes generated from the MK/platelet lineage would be fully functional and capable of correcting lysosomal deficits in diseased cells.In this study, we used a mouse model of Hurler syndrome, which is the severe form of mucopolysaccharidosis type I (MPS I), one of most common LSDs. It is caused by the deficiency of α-l-iduronidase (IDUA) and consequent accumulation of glycosaminoglycans (GAGs) (12, 13). We show that MKs are capable of producing large amounts of IDUA with proper catalytic function, lysosomal trafficking and receptor-mediated uptake, which could be sorted to and stored within platelets. The IDUA can be released directly into the extracellular space or within microparticles (MPs) during MK maturation or platelet activation, while retaining its ability to cross-correct cells derived from patients with MPS I. 相似文献
54.
Ismail Bozkurt Yasar Ozturk Guven Guney Burak Arslan Ozlem Gulbahar Yahya Guvenc Salim Senturk Mesut Emre Yaman 《International journal of clinical and experimental pathology》2022,15(1):20
Traumatic brain injury (TBI) continues to be a significant public healthcare concern. Neuroinflammation that occurs in the secondary phase of TBI leads to cognitive and physical dysfunction. A number of therapeutic modalities have been evaluated in an attempt to find a suitable treatment. The only drug approved for the treatment of idiopathic pulmonary fibrosis, pirfenidone, has been evaluated for its antifibrotic, anti-inflammatory, and anti-oxidant properties for various disorders, but this is the first study to examine its effects in an experimental TBI model. Twenty-four Wistar rats were randomly divided into three groups: control, trauma, and pirfenidone. The two latter groups underwent experimental diffuse cortical injury mimicking TBI. Neurological assessment was performed using the Garcia test, histological analysis was performed to examine neuroprotective and anti-inflammatory effects, and biochemical analyses of neuron-specific enolase (NSE), S-100B, caspase-3, and thiobarbituric acid reactive substances were performed. The pirfenidone group had a better Garcia test score (P=0.001), an increased anti-inflammatory effect (P<0.001), and an enhanced neuroprotective effect (P=0.007) along with decreased NSE, S100B, and TBARS levels compared to the trauma group. However, pirfenidone did not show a beneficial effect on caspase-3 levels. Pirfenidone may help decrease mortality and morbidity rates after TBI through its anti-inflammatory and antioxidant effects. 相似文献
55.
Cdric Rossi Marie Tosolini Pauline Gravelle Sarah Pericart Salim Kanoun Solene Evrard Julia Gilhodes Don-Marc Franchini Nadia Amara Charlotte Syrykh Pierre Bories Lucie Oberic Loïc Ysebaert Laurent Martin Selim Ramla Philippine Robert Claire Tabouret-Viaud Ren-Olivier Casasnovas Jean-Jacques Fourni Christine Bezombes Camille Laurent 《Haematologica》2022,107(1):221
56.
Bergman David Modh Ankit Schultz Lonni Snyder James Mikkelsen Tom Shah Mira Ryu Samuel Siddiqui M. Salim Walbert Tobias 《Journal of neuro-oncology》2020,148(2):353-361
Journal of Neuro-Oncology - Outcomes for patients with recurrent high-grade glioma (HGG) progressing on bevacizumab (BEV) are dismal. Fractionated stereotactic radiosurgery (FSRS) has been shown to... 相似文献
57.
58.
59.
A S Salim 《Journal of psychosomatic research》1987,31(1):85-90
In the rat, stress activates the hypothalamus inducing central sympathetic discharge and delivery of alpha-adrenergic stimulation to the stomach by the adrenergic hypothalamovagal pathway. This stimulation controls intragastric blood flow and 5-HT release. Administration of reserpine produces stress pharmacologically and stimulates the mentioned pathway. Six hours after intraperitoneal reserpine (5 mg/kg), gastric mucosal lesions are produced in all rats. These lesions are vascular in origin and do not require gastric acid or duodenal contents for their development. However, reflux of duodenal contents into the stomach is associated with this pathway stimulation and increases lesion severity. Stimulation of the pathway with a single intraperitoneal injection of reserpine (5 mg/kg) every 24 h for five days produces chronic gastric ulceration in 80% of rats demonstrating the relationship between stress and chronic gastric ulceration. In addition it is observed that the duration of stress in the rat determines the nature of the gastric lesion produced. 相似文献
60.